21 start-ups selected to innovate for healthy ageing, feat. SepTec

The awards are part of the Healthy Longevity Global Competition – a multiyear, multimillion-dollar international competition seeking breakthrough innovations to extend human health and function later in life.

Founded by the U.S. National Academy of Medicine, the competition has been running for two years and calls on teams and individuals from diverse backgrounds including science, medicine, technology, finance, and social sciences to submit novel and innovative ideas. The Competition includes a three-tiered structure of awards: a first phase of Catalyst Awards, a second phase Accelerator Award, and a third Grand Prize phase.

EIT Health is administering and funding the Catalyst Awards, participating in the first phase of the Global Competition to assist in the immediate need for solutions to combat ageing around the world, which provides an opportunity for ventures to focus on physical, mental, and social well-being for people as they age.

“I am pleased to continue our collaboration with EIT Health, and together with all of our global partners, welcome a new cohort of scientists, innovators, and entrepreneurs for their ambitious work to extend the human health span. This diverse and cross-disciplinary group is helping to improve the physical, mental, and social wellbeing of people as they age. We look forward to continuing our support of new researchers in the field of longevity to stimulate breakthroughs that will impact the lives of generations to come,” said National Academy of Medicine President Victor J. Dzau.

21 start-ups have received a Catalyst Award from EIT Health as part of the competition, with each receiving up to €50,000 seed funding to advance their product or service:

Novus Diagnostics LTD (Ireland): Novus Diagnostics has developed SepTec, a next generation sepsis detection device that is making significant strides towards addressing the vital need for rapid and accurate sepsis diagnosis.